Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
European Union
MedTech
Beckman Coulter grows Alzheimer’s dx portfolio with CE mark
Beckman Coulter expanded its portfolio of Alzheimer’s disease diagnostics by earning a CE mark in Europe for its Access p-Tau217 assay.
Joseph Keenan
Jul 7, 2026 10:55am
Roche garners EU approval on label expansions for dx platform
Jun 11, 2026 9:02am
Predicta links with Spanish university to offer blood cancer dx
Jun 11, 2026 8:13am
Kurma closes €215M Europe-focused fund to spend on 20 biotechs
Apr 23, 2026 8:30am
BD taps Sinteco for European pharmacy robotics partnership
Mar 11, 2026 10:50am
Newly minted MiniMed nets CE mark for 780G pump, Instinct CGM
Mar 11, 2026 10:05am
